Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide
在阿比特龙或恩扎卢胺治疗后疾病进展的转移性去势抵抗性前列腺癌中,加用奥帕加尼的II期临床试验
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71633
Brown, Jacqueline T; Nazha, Bassel; Ferreira, Anna C; Armeson, Kent; Hill, Elizabeth G; Ogretmen, Besim; Mehrotra, Shikhar; Brisendine, Alan; Magrath, George; Plasse, Terry F; Gourdin, Theodore Stewart; Kucuk, Omer; Lilly, Michael